Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP18ak0101087)
Japan Society for the Promotion of Science (23591666)
Japan Kawasaki Disease Research Center
Article History
Received: 29 February 2020
Accepted: 3 September 2020
First Online: 6 October 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: A. Matsuda obtained the human immunoglobulin preparations (IVIG) used in this study from Japan Blood Products Organization (JB). The authors have no conflicts of interest directly relevant to the contents of this article.